Searchable abstracts of presentations at key conferences in endocrinology

ea0090p665 | Endocrine-related Cancer | ECE2023

A rare cause of bilateral adrenal masses

Santos Sara , Calheiros Raquel , Souteiro Pedro , Oliveira Joana , Inacio Isabel , P Santos Ana , Torres Isabel

Introduction: Bilateral adrenal masses may appear in the context of metastatic disease, adrenal congenital hyperplasia, primary tumors or infections, among others. Primary adrenal lymphoma is rare, accounting for approximately 1% of cases of non-Hodgkin lymphoma. Clinical case: 47-year-old woman, with a history of erythema nodosum and left hemithyroidectomy in the context of benign nodular disease. She presented with persistent fever and tiredne...

ea0090p433 | Pituitary and Neuroendocrinology | ECE2023

Lanreotide-Induced Acalculous Acute Pancreatitis in a Person with Acromegaly: an Unexpected Severe Side Effect

Ramalho Diogo , Alves Helena , Henrique Carmona Alexandrino Jorge , Jesus Nuno , Melo Gustavo , Joao Oliveira Maria

Introduction: Somatostatin analogues (SA) are the first-line treatment for Acromegaly in patients whose surgery failed to achieve cure or it was contraindicated. The main reported adverse events of SA are mild and transient, and include nausea, abdominal cramps, diarrhea and flatulence. Other side effects are of rare occurrence.Case report: The authors describe a case of a 44-year-old previously asymptomatic male patient with a growth hormone-secreting p...

ea0090p692 | Pituitary and Neuroendocrinology | ECE2023

Characterisation of the clinical and biologic behaviour of acromegaly caused by pluri-hormonal tumours in a cohort of 75 patients

Martins Ferreira Mafalda , Carreira Ana , Cardoso Luis , Oliveira Patricia , Melo Miguel , Paiva Isabel

Introduction: The clinical and biochemical spectrum of pituitary acromegaly is wide and variable. There are pure somatotroph tumors(ST), immunohistochemically positive only for GH, and pluri-hormonal(PL), also positive for other hormones, and they appear to have different presentations and responses to treatment.Aims: To compare the clinical presentation, imaging characteristics and response to treatment of acromegalic patients according to the pituitary...

ea0090p174 | Reproductive and Developmental Endocrinology | ECE2023

Congenital Adrenal Hyperplasia – When does Gender Identity Begin?

Lopes Sofia , Ferreira Mafalda , Araujo Barbara , Ruas Luisa , Paiva Sandra , Oliveira Patricia , Paiva Isabel

Introduction: Congenital adrenal hyperplasia (CAH) is a genetic condition which impairs enzymatic steroidogenesis of the adrenal cortex, leading to excessive androgen production. CAH phenotype is heterogeneous. In the mildest forms, it can present with hirsutism, acne and menstrual irregularities. Problems related to gender identification arise in about 5% of people with CAH with a 46,XX karyotype.Objective: We present the case of a young female-to-male ...

ea0090p732 | Reproductive and Developmental Endocrinology | ECE2023

Impact of chromium picolinate on testicular steroidogenesis

Moreira Ruben , Moreira Silvia , Alves Marco , Oliveira Pedro , de Lourdes Pereira Maria

Low testosterone levels are one of the causes of male infertility since testosterone is a crucial hormone for the regular functioning of the male reproductive tract. Testosterone is produced by Leydig cells (LC) in a process called testicular steroidogenesis, and if these cells are injured in any way, then the steroid production may be compromised. Endocrine Disrupting Chemicals (EDCs) are a group of substances that disturbs hormonal signaling. Their chemical nature and mode o...

ea0090ep183 | Calcium and Bone | ECE2023

Severe hypocalcemia during respiratory alkalosis reveals a case of Pseudohipoparathyroidism type 1B

Roque Catarina , Fonseca Ricardo , Osorio Ana Sofia , Oliveira Sofia , Machado Catarina

We present a case of Inactivating PTH/PTHrP signalling disorder (IPPSD) revealed in aduthood in the context of respiratory alkalosis caused by covid-19 infection that led to worsening of the preexisting hypocalcemia and intensification of the usual hypocalcemic symptoms. A 39 year old female with history of subclinical hypothyroidism and bilateral cataracts was admited due to hypoxemia in the context of severe covid-19 infection with bilateral pulmonary infiltrates. She was vi...

ea0090ep187 | Calcium and Bone | ECE2023

Hyperparathyroidism Jaw Tumour Syndrome in Pregnancy: A rare coexistence

Lopes Sofia , Monsanto Alice , Ferreira Mafalda , Ventura Mara , Ruas Luisa , Oliveira Patricia , Paiva Isabel

Introduction: Only <1% of cases of primary hyperparathyroidism (PHPT) occur during pregnancy. PHPT increases risk of complications such as miscarriage, premature birth and life-threatening maternal hypercalcemic crises. Hyperparathyroidism Jaw Tumor Syndrome (HPT-JT) is a rare inherited cause of PHPT, resulting from CDC73 gene mutations. There are a few reports described about HPT-JT in pregnancy. Although parathyroidectomy is the definite treatment for PHPT, given the sca...

ea0090ep706 | Pituitary and Neuroendocrinology | ECE2023

Translation into Portuguese and cultural adaptation of the Literacy Independent Cognitive Assessment

Santos Lucas B. , Kellner Michael , Oliveira Walter , Faro Andre , Oliveira Carla R P , Batista Vanderlan O , Oliveira-Santos Alecia A , de Brito Iris de Vita Alves , Almeida Viviane , Villar-Gouy Keila R , Leal Angela , Amorim Rivia S , Melo Enaldo V , Santos Elenilde G , Salvatori Roberto , Aguiar-Oliveira Manuel H.

Population aging has become a universal worldwide phenomenon. Developing countries (such as Portuguese-speaking countries, with a high rate of illiteracy) will see the greatest increase in the absolute number of elderly people, and dementia disorders will pose enormous challenges to public health in these countries. Although the decline in GH secretion with age has been associated with deleterious conditions of aging, our understanding is the opposite, that the decline in GH s...

ea0090ep721 | Pituitary and Neuroendocrinology | ECE2023

An international, simulated-use study assessing nurses’ preferences between two lanreotide syringes (Somatuline Autogel vs Pharmathen) for treatment of neuroendocrine tumours (NETs) and/or acromegaly: PRESTO 3

Ferone Diego , Martin Wendy , Williams Jessica , Houchard Aude , Pommie Christelle , Ribeiro-Oliveira Antonio , Grossman Ashley B

Introduction/Background: Patients with NETs and acromegaly are commonly treated with somatostatin analogues (SSAs), such as octreotide and lanreotide depot formulations. The Pharmathen syringe is now available in several European countries and the USA for lanreotide depot injection. When using SSAs, confidence in and ease of use with syringes is important for decision-making in long-term therapy.Aims: PRESTO 3 compared nursesÂ’ preference for the Som...

ea0090ep761 | Pituitary and Neuroendocrinology | ECE2023

Delayed onset of pasireotide-induced hyperglycemia: Report of two cases

Stormann Sylvere , Schilbach Katharina , Amereller Felix , Schweizer Junia Ribeiro de Oliveira Longo , Schopohl Jochen

Introduction: Pasireotide is a potent somatostatin analogue (SSA) and used in therapy-refractory acromegaly, commonly after failure of treatment with first-generation SSA. However, it may induce severe hyperglycemia, which usually occurs rapidly after initiation of therapy and in general gradually improves over time. We here present two cases of young male patients who developed severe pasireotide-induced hyperglycemia after several years of treatment.Ca...